Bagsværd, Denmark, 7 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
Further information
| Media: | ||
| Katrine Sperling | +45 4442 6718 | |
| Ken Inchausti (US) | +1 609 786 8316 | |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | |
| Anders Mikkelsen | +45 3079 4461 | |
| Christina Kjær | +45 3079 3009 |
Company announcement No 41 / 2018
Attachment